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1. Introduction 
The blood anticoagulant activity of heparin 
depends on its ability to bind, and thereby activate, 
antithrombin, a plasma protein that inhibits the 
proteinases of the so-called coagulation cascade [ 11. 
Only a fraction (-1/3rd) of the molecules in heparin 
preparations binds with high affinity to antithrombin 
and this fraction accounts for most of the anticoagu- 
lant activity of the unfractionated material [2-41. 
Attempts to define the structural basis for the inter- 
action between heparin and antithrombin led to 
partially conflicting results. While it was claimed 
that the heparin structure required for binding to 
antithrombin is contained within a tetrasaccharide 
sequence [5], we proposed a more extended binding 
region [6]. Our conclusion was based on the isolation 
of oligosaccharides with high affinity for antithrom- 
bin, following partial depolymerization of heparin 
with bacterial heparinase [7] or with nitrous acid [6]. 
The oligosaccharides were tentatively identified as 
dodeca- or tetradecasaccharides. However, no attempt 
was made to define the extent of the actual binding 
sequence by selecting for the smallest possible oligo- 
saccharide yet capable of binding with high affinity 
to antithrombin. Here, such a component has been 
isolated and identified as an octasaccharide. The loca- 
tion in the octasaccharide molecule of a tetrasaccha- 
ride structure (IdUA+GlcNac+GlcUA+GlcNSOi), 
implicated in the antithrombin-binding sequence 
[5,6], has been determined. 
Ab&viations: IdUA, L-iduronic acid; GlcUA, Dglucuronic 
acid; GlcNAc, 2acetamido-2deoxyglucose; GlcNSO;, ~-SUE 
amide-2deoxyglucose; the location of O-sulfate groups is 
indicated in parentheses; glycosidic linkages are indicated by 
arrows (-1 
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2. Materials and methods 
The heparin preparation used was as in [3]. 
D&0-sulfated iduronosyl-2,5anhydro- [ 1 -3H] mannitol 
was prepared from deamination products of hepa- 
rin [8]. 
Methods for the determination of hexuronic acid 
and radioactivity have been reported [9]. Affinity 
chromatography on antithrombin-Sepharose was 
done as in [lo], with the exception that human anti- 
thrombin (Kabi AB, Stockholm) was used; the proce- 
dure was adapted to a total gel volume of either 3 ml 
or 500 ml. 
Gel chromatography of oligosaccharides was per- 
formed on a column (3 X 250 cm) of Sephadex G-50, 
eluted with 1 M NaCl at 16 ml/h. Periodate oxidation 
(pH 7,37”(Z) followed by alkali treatment was done 
by the procedure in [ 111. 
Degradation of heparln with nitrous acid was done 
as in [ 121, with the exception that the temperature 
was kept at -10°C. For additional experimental 
details, see the legends to figures. 
3. Results and discussion 
Heparin (1 g) was treated with nitrous acid at 
-1O’C for 40 mm and the products were fraction- 
ated by affinity chromatography on antithrombin- 
Sepharose (see fig.1). Material retained by the affinity 
matrix at low ionic strength (0..05 M NaCl-0.05 M 
Tris) was recovered by salt-gradient elution [lo] and 
a portion of the product was reduced with sodium 
boro[3H]hydride [8]. The resulting labeled oligosac- 
charides (with terminal 2,5anhydro- [ 1 -3H] mannitol 
residues) were separated in a second affinity-chroma- 
tography step into 3 fractions with different affni- 
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ties for antithrombin (fig.1). The high-affinity frac- 
tion eiuted in the same salt con~ntration range as a 
heparin fraction with an anticoagulant activity of 
-250 units/mg (unpublished). 
The ~~-af~nity fraction (HA in frg.1) was mixed 
with unlabeled reference oligosaccharides, obtained 
by partial deamination of heparin, and was then sub- 
jected to gel chromato~aphy on Sephadex G-50 
(fig.2A). It separated into 3 peaks of labeled material, 
corresponding to octa-, deca- and dodecasaccharides, 
respectively. No labeled components smaller than 
f- 
3.0. 
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Fig.1. Afftity c~omato~aphy of heparin oligosaccharides 
on antithrombin-Sepharose. Heparht (1 g) was deaminated 
at -10°C in 500 ml total vol. [12]. After 40 min the reaction 
was interrupted by adjusting to pH 8.0 with 2 M Tris, and the 
mixture was concentrated and desalted by passage through a 
column of Sephadex G-l 5, eluted with 10% ethanol. The 
products were separated by affinity chromatography [ 1 O] on 
a column of ~tit~omb~-Sep~ose (500 ml bed vol.). 
Material eluted at 0.5-3.0 M NaCl (-6% of the starting 
material) was recovered, and a portion (100 pg uranic acid) 
was reduced with sodium boro [3H]hydride, as in IS]. The 
jH-labeled oligosaccharides were mixed with 2 mg heparin 
and applied to a small column (3 ml) of antithrombin- 
Sepharose. Following gradient elution, effluent fractions 
were analyzed for uranic acid by the carbazole reaction (0) 
or for aH radioactivity (0). Fractions of low (LA, eluted at 
0.05-0.45 M NaCl), medium (MA, 0.45-0.65 M NaCl) and 
high (HA, 0.65-l .2 M NaCl) afftity for ~tit~omb~, 
respectively, were pooled and analyzed further by gel chro- 
matography. 
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octasaccharide w re detected. The medium-affinity 
fraction (MA in fig-l), and the low-affinity fraction 
(LA in fig.1) both yielded essentially the same three 
peaks (3H-labeled material in fig.ZB and 2C, respec- 
tively), but in addition, a shoulder in the hexasac- 
charide region. In contrast, the material that lacked 
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Fig.2. Gel chromatography on Sephadex G-50 of ‘H-labeled 
oligosaccharides with (A) high, (B) medium, and (C) low 
affinity for antithrombin. The isolation of the oligosaccha- 
rides is described in the legend to fii.1. The sample (100 X 10” 
cpm ‘H) iu panel (A) was mixed with 100 mg reference oligo- 
saccharides prior to chromatography; these oligosaccharides 
were prepared by partial deaminative cleavage of heparin 
(23 mm reaction time), essentially as in fig.1. Effluent frac- 
tions were analyzed for ‘H radioactivity (0) or for uranic 
acid (0). The carbazole-positive material in panel (C) is a 
sample of the low-affiity o~go~cch~ides recovered with 
the break-through fraction of the initial, large-scale affinity 
chromatography in fig.1. The number of monosaccharide 
units in the various ohgosaccharides i  indicated above the 
appropriate peaks of reference oligosaccharides. These num- 
bers were assigned on the assumption that each two consecu- 
tive species diifer by a disaccharide unit; the identity of the 
most retarded component, a disaccharide, was ascerttained by 
co-chromatography with di_O-sulfated iduronosylanhydro- 
[3H]mannitol. 
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Fig-S. Gel c~omato~aphy on Sephadex G-50 of 3H-labeled 
autithrombin-bhrcimg octasaccharide, b fore (0) and after (a) 
treatment with periodate-alkali. For preparation of octasac- 
charide heparin was treated with nitrous acid at -10°C for 
35 mm and the products precipitable with 10 vol. ethanol 
were fractionated by affinity chromatography on antithrom- 
bin-Sepharose. Material eluting at >0.9 M NaCi was recov- 
ered and fractionated by gel c~omato~phy on Sephadex 
G-SO. Effluent fractions corresponding to octasaccharides 
were pooled and reduced with sodium boro[3H]hydride; the 
resulting labeled octasaccharide was purified by repeated 
affinity chromatography on autithrombin-Sepharose fol-
lowed by gel chromatography on Sephadex G-50. Before 
analysis by gel chromato~aphy the fti sample of periodate- 
alkali-treated octasaccharide was mixed with 100 mg refer- 
ence oliiosaccharides (see the legend to f@,2); the elution 
pattern of these oligosaccharides was recorded by the car- 
bazole reaction (A). For explanation of the numbering of the 
oligosaccharide p aks, see tIg.2. 
affinity for antithromb~ at 0.05 M NaCl (Le., the 
bulk of deamination products, -90% of the starting 
material, removed in the initial, large-scale, affmity- 
chromatography step; carbazole-positive material 
in fig,2C) consisted largely of di-, tetra- and hexa- 
1 2 3 4 
qoo- 
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saccharides. The absence of such components in the 
high-affinity fraction clearly demonstrates that the 
smallest heparin fragment with high affinity for anti- 
thrombin, that can be obtained by degradation with 
nitrous acid, is an octasaccharide. 
Studies on the antithrombin-binding region in pig 
intestinal mucosa heparin showed the occurrence of a 
+IdUA+GlcNAc+GlcUA-*GlcNSO~ tetrasaccharide 
sequence, in which both uranic acid moieties were 
non-sulfated [5,6]. The location of this sequence in 
the antithrombin-binding, 3H-labeled octasaccharide 
was established by periodate oxidation of the non- 
sulfated uranic acid units followed by alkaline cleav- 
age of the products; the labeled fragment(s) formed 
should correspond to the interjacent sugar units 
between the glucuronic acid residue and the anhydro- 
[3H]mannitol end group (see analogous experiment 
in [S]). The actasaccharide was quantitatively cleaved, 
yielding a distinct peak of labeled material that was 
somewhat retarded in relation to a reference hexa- 
saccharide (fig.3) and would thus be identical with 
the pentasaccharide, [GlcNSO~+IdUA(2-OSO;)]2+ 
anhydro- [ 3H]mannitol (no 6-O-sulfate groups are 
indicated). The release of a labeled pentasaccharide 
can only be explained by the octasaccharide structure 
shown in fig.4, with the pe~odate-su~eptible @cur- 
onic acid unit located in position 3, and the non- 
sulfated iduronic acid component of the TdUA+ 
GlcNAc+GlcUA+GlcNSO~+ sequence constituting 
the non-reducing terminal unit of the intact octa- 
saccharide. 
Our knowledge of the interaction between heparin 
and antithrombin is still fragmentary; little is thus 
known regarding which of the components of the 
octasaccharide structure are acutally involved in the 
binding to the protein. Since the nitrous acid reagent 
5 6 7 8 
Fig.4. Tentative structure for the antithrombiu-binding octasaccharide rived from pig mucosal heparm. X = H or SO;. The 
‘H-labeled 2,S-anhydromannitol residue in position 8 corresponds toanN-sulfated glucosamiue unit in the intact polysaccharide. 
The structure shown represents he majority of autithrombiu-binding sequences in pig mucosal heparin. However, structural vari- 
ants compatible with affinity for antithrombin cannot be excluded (see [6] regarding ~e~~cety~uco~~ne and glucuronic 
acid units in positions 2 and 3, respectively). 
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used to depolymerize heparin will attack at most 
every other glycosidic bond (the GlcNSO;+ linkages), 
it is obvious that the actual binding sequence will 
not necessarily span the entire octasaccharide struc- 
ture; for instance, it seems likely that the anhydro- 
mannitol end group (position 8) may correspond to a 
glucosamine r sidue located outside the antithrom- 
bin-binding sequence in the intact heparin chain. 
Nevertheless, this region clearly extends beyond the 
tetrasaccharide s gment (positions l-4 in fig.4) impli- 
cated in [5]. Recent results demonstrate, in accord 
with this conclusion, that selective removal of either 
one of the two N-sulfate groups at positions 4 and 6, 
respectively, results in a distinct and appreciable oss 
in affinity of the octasaccharide for antithrombin 
(J. R., L. T., M. H66k, U. L., unpublished). 
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